These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 33815284)

  • 1. Metformin Strongly Affects Gut Microbiome Composition in High-Fat Diet-Induced Type 2 Diabetes Mouse Model of Both Sexes.
    Silamiķele L; Silamiķelis I; Ustinova M; Kalniņa Z; Elbere I; Petrovska R; Kalniņa I; Kloviņš J
    Front Endocrinol (Lausanne); 2021; 12():626359. PubMed ID: 33815284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Region-Specific Effects of Metformin on Gut Microbiome and Metabolome in High-Fat Diet-Induced Type 2 Diabetes Mouse Model.
    Cheng M; Jia X; Ren L; Chen S; Wang W; Wang J; Cong B
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial variation of the gut microbiome in response to long-term metformin treatment in high-fat diet-induced type 2 diabetes mouse model of both sexes.
    Silamiķele L; Saksis R; Silamiķelis I; Kotoviča PP; Brīvība M; Kalniņa I; Kalniņa Z; Fridmanis D; Kloviņš J
    Gut Microbes; 2023; 15(1):2188663. PubMed ID: 36927522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
    Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
    Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.
    Forslund K; Hildebrand F; Nielsen T; Falony G; Le Chatelier E; Sunagawa S; Prifti E; Vieira-Silva S; Gudmundsdottir V; Pedersen HK; Arumugam M; Kristiansen K; Voigt AY; Vestergaard H; Hercog R; Costea PI; Kultima JR; Li J; Jørgensen T; Levenez F; Dore J; ; Nielsen HB; Brunak S; Raes J; Hansen T; Wang J; Ehrlich SD; Bork P; Pedersen O
    Nature; 2015 Dec; 528(7581):262-266. PubMed ID: 26633628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin alters the duodenal microbiome and decreases the incidence of pancreatic ductal adenocarcinoma promoted by diet-induced obesity.
    Dong TS; Chang HH; Hauer M; Lagishetty V; Katzka W; Rozengurt E; Jacobs JP; Eibl G
    Am J Physiol Gastrointest Liver Physiol; 2019 Dec; 317(6):G763-G772. PubMed ID: 31545922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of metformin, saxagliptin and repaglinide on gut microbiota in high-fat diet/streptozocin-induced type 2 diabetic mice.
    Tang Y; Yan M; Fang Z; Jin S; Xu T
    BMJ Open Diabetes Res Care; 2024 May; 12(3):. PubMed ID: 38719505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiome encoded purine and amino acid pathways present prospective biomarkers for predicting metformin therapy efficacy in newly diagnosed T2D patients.
    Elbere I; Orlovskis Z; Ansone L; Silamikelis I; Jagare L; Birzniece L; Megnis K; Leskovskis K; Vaska A; Turks M; Klavins K; Pirags V; Briviba M; Klovins J
    Gut Microbes; 2024; 16(1):2361491. PubMed ID: 38868903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin-induced changes of the gut microbiota in patients with type 2 diabetes mellitus: results from a prospective cohort study.
    Gao Y; Zhao T; Lv N; Liu S; Yuan T; Fu Y; Zhao W; Zhu B
    Endocrine; 2024 Sep; 85(3):1178-1192. PubMed ID: 38761345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus.
    Lee CB; Chae SU; Jo SJ; Jerng UM; Bae SK
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin targets intestinal immune system signaling pathways in a high-fat diet-induced mouse model of obesity and insulin resistance.
    Brīvība M; Silamiķele L; Kalniņa I; Silamiķelis I; Birzniece L; Ansone L; Jagare L; Elbere I; Kloviņš J
    Front Endocrinol (Lausanne); 2023; 14():1232143. PubMed ID: 37795356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic modelling of the human gut microbiome in type 2 diabetes patients in response to metformin treatment.
    Ezzamouri B; Rosario D; Bidkhori G; Lee S; Uhlen M; Shoaie S
    NPJ Syst Biol Appl; 2023 Jan; 9(1):2. PubMed ID: 36681701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin-induced changes in the gut microbiome and plasma metabolome are associated with cognition in men.
    Rosell-Díaz M; Petit-Gay A; Molas-Prat C; Gallardo-Nuell L; Ramió-Torrentà L; Garre-Olmo J; Pérez-Brocal V; Moya A; Jové M; Pamplona R; Puig J; Ramos R; Bäckhed F; Mayneris-Perxachs J; Fernández-Real JM
    Metabolism; 2024 Aug; 157():155941. PubMed ID: 38871078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of metformin on metabolic improvement and gut microbiota.
    Lee H; Ko G
    Appl Environ Microbiol; 2014 Oct; 80(19):5935-43. PubMed ID: 25038099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of gut microbiota in type 2 diabetes to hypoglycemic agents.
    Zhang F; Wang M; Yang J; Xu Q; Liang C; Chen B; Zhang J; Yang Y; Wang H; Shang Y; Wang Y; Mu X; Zhu D; Zhang C; Yao M; Zhang L
    Endocrine; 2019 Dec; 66(3):485-493. PubMed ID: 31410749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of berberine and metformin on intestinal inflammation and gut microbiome composition in db/db mice.
    Zhang W; Xu JH; Yu T; Chen QK
    Biomed Pharmacother; 2019 Oct; 118():109131. PubMed ID: 31545226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 16S rRNA Sequencing and Metagenomics Study of Gut Microbiota: Implications of BDB on Type 2 Diabetes Mellitus.
    Zhang L; Luo J; Li X; Guo S; Shi D
    Mar Drugs; 2020 Sep; 18(9):. PubMed ID: 32957565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India.
    Alvarez-Silva C; Kashani A; Hansen TH; Pinna NK; Anjana RM; Dutta A; Saxena S; Støy J; Kampmann U; Nielsen T; Jørgensen T; Gnanaprakash V; Gnanavadivel R; Sukumaran A; Rani CSS; Færch K; Radha V; Balasubramanyam M; Nair GB; Das B; Vestergaard H; Hansen T; Mande SS; Mohan V; Arumugam M; Pedersen O
    Genome Med; 2021 Mar; 13(1):37. PubMed ID: 33658058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut.
    de la Cuesta-Zuluaga J; Mueller NT; Corrales-Agudelo V; Velásquez-Mejía EP; Carmona JA; Abad JM; Escobar JS
    Diabetes Care; 2017 Jan; 40(1):54-62. PubMed ID: 27999002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin treatment for 8 days impacts multiple intestinal parameters in high-fat high-sucrose fed mice.
    Bravard A; Gérard C; Defois C; Benoit B; Makki K; Meugnier E; Rainteau D; Rieusset J; Godet M; Vidal H
    Sci Rep; 2021 Aug; 11(1):16684. PubMed ID: 34404817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.